<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0005110'>Atrial fibrillation</z:hpo> (AF) is a common <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> in the setting of <z:hpo ids='HP_0011009'>acute</z:hpo> coronary syndrome and <z:hpo ids='HP_0011009'>acute</z:hpo> ST-elevation <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">STEMI</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>This review summarizes recent evidence on the clinical and prognostic significance of pre-existent and new-<z:hpo ids='HP_0003674'>onset</z:hpo> AF in <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">STEMI</z:e> patients and highlights new emerging predictors of AF development in the era of contemporary treatment </plain></SENT>
</text></document>